Drugs
-
?
-
Drug Safety and Availability
Information for consumers and health professionals on new drug warnings and other safety information, drug label changes, and shortages of medically necessary drug products.
Drug Safety Communications
- Comunicado de la FDA sobre la seguridad de los medicamentos: Estudio de seguridad en curso sobre el medicamento Mirapex (pramipexole) para la enfermedad de Parkinson y el posible riesgo de insuficiencia cardĂaca
- FDA Drug Safety Communication: Ongoing safety review of Parkinson’s drug Mirapex (pramipexole) and possible risk of heart failure
- FDA Drug Safety Communication: Rare cases of serious burns with the use of over-the-counter topical muscle and joint pain relievers
Drug Recalls
- Watson Issues Voluntary Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized and Superpotent Tablets
- Evol Nutrition Associates, Inc./ Red Dawn Issues Voluntary Nationwide Recall of Dietary Supplements Mojo Nights and Mojo Nights for Her Because of Potential Health Risk
- Body Basics Inc. Issues a Voluntary Nationwide Recall of ACTRA-Sx 500 Capsules, Lot 008-A, due to Potential Health Risks
?
Contact FDA
Toll Free
(855) 543-3784, or
(301) 796-3400
Human Drug Information
Division of Drug Information (CDER)
Office of Communications
10001 New Hampshire Avenue
Hillandale Building, 4th Floor
Silver Spring, MD 20993
-
-